Mitochondrial dynamic disorder is involved in myocardial ischemia/reperfusion (I/R) injury. To explore the effect of mitochondrial calcium uniporter (MCU) on mitochondrial dynamic imbalance under I/R and its related signal pathways, a mouse myocardial I/R model and hypoxia/reoxygenation model of mouse cardiomyocytes were established. The expression of MCU during I/R increased and related to myocardial injury, enhancement of mitochondrial fission, inhibition of mitochondrial fusion and mitophagy. Suppressing MCU functions by Ru360 during I/R could reduce myocardial infarction area and cardiomyocyte apoptosis, alleviate mitochondrial fission and restore mitochondrial fusion and mitophagy. However, spermine administration, which could enhance MCU function, deteriorated the above-mentioned myocardial cell injury and mitochondrial dynamic imbalanced. In addition, up-regulation of MCU promoted the expression and activation of calpain-1/2 and downregulated the expression of Optic atrophy type 1 (OPA1). Meantime, in transgenic mice (overexpression calpastatin, the endogenous inhibitor of calpain) I/R model and OPA1 knock-down cultured cell. In I/R models of transgenic mice over-expressing calpastatin, which is the endogenous inhibitor of calpain, and in H/R models with siOPA1 transfection, inhibition of calpains could enhance mitochondrial fusion and mitophagy, and inhibit excessive mitochondrion fission and apoptosis through OPA1. Therefore, we conclude that during I/R, MCU up-regulation induces calpain activation, which down-regulates OPA1, consequently leading to mitochondrial dynamic imbalance. K E Y W O R D S calpain, ischemia/reperfusion (I/R), mitochondrial calcium uniporter (MCU), mitochondrial fission, mitophagy | 7831 GUAN et Al.
| INTRODUC TI ON
Although revascularization is the most effective therapy to rescue ischaemic cardiomyocytes, reperfusion process could result in an extra cell loss and impair heart function. This phenomenon is known as ischemia/reperfusion injury (I/R). 1 Mitochondria are enriched in cardiomyocyte and maintain their function by constantly undergoing fission and fusion and eliminating damaged part through mitophagy. 2 Key proteins of mitochondrial dynamic pertain to GTPase proteins. Mitofusin 1 (MFN1), Mitofusin 2 (MFN2) and Optic atrophy type 1 (OPA1) located in mitochondrial membrane dominate mitochondrial fusion, while dynamin-related protein1 (Drp1) translocates to the outer mitochondrial membrane and binds with receptors such as Fis1, MIEF, Mff, and mid49/51 to lead mitochondrial fission. PINK1 aggregates when the outer membrane potential of the damaged mitochondria decreases, attracts PARKIN to transfer to the outer mitochondrial membrane and initiates selective mitophagy. According to recent researches, the imbalance of mitochondrial fission, fusion and mitophagy plays vital role in I/R. 3 I/R induces excessive mitochondrial fission and fragments, and down-regulates fusion and mitophagy, which results in release of cytochrome C and caspase family proteins, and consequent apoptotic cascading effect. 4 On the other hand, inhibition of mitochondrial fission or restoration of fusion and mitophagy seems protective in I/R. 5 Mitochondrial calcium uniporter (MCU), localized in inner mitochondrial membrane (IMM), is the most important unidirectional channel responsible for Ca 2+ influx into mitochondria. MCU regulates mitochondrial calcium homeostasis that is essential to ATP production and metabolism. 6 When elevated cardiac output is demanded, MCU is a regulator of momentary mitochondrial Ca 2+ loading to quickly match cardiac workload with ATP production. 7 Nevertheless, upon cardiac I/R stress, MCU is responsible for mitochondrial Ca 2+ overload, opening of the mitochondrial permeability transition pore (MPTP) and cell death. 8 Down-regulation of MCU by siRNA seemed protective from I/R injury in vitro. 8 Recently, it was reported that the up-regulation of MCU may even lead to increase intracytoplasmic calcium through sarcoplasmic reticulum-mitochondria communication. 9 However, whether MCU is involved in the defective mitochondrial fission/fusion and mitophagy in myocardial I/R injury, the underlying mechanism remains unknown.
Calpains belong to the calcium-dependent thiol-protease family and include 15 isoforms. Among them, μ-calpain (calpain-1) and m-calpain (calpain-2) were the main isoforms of calpains expressed in cardiomyocytes. 10 During reperfusion, calpains are activated by calcium overload and play a role in I/R injury via cleavage of structural proteins and modification of pro-apoptotic proteins. 11 Calpain enhanced mitochondrial fission by activating calcineurin that phosphorylates the dynamin-related protein 1 (Drp1) in neural cell model. 12 However, if calpain was downstream regulated by MCU and impacted on mitochondrial fusion, the mitophagy during myocardial I/R is still elusive.
Located in IMM, OPA1 governs mitochondrial fusion. 13 Disruption of OPA1 under pathologic conditions would lead to increase mitochondrial fission, fragmentation and even cell death. 14 
| Ischemia/reperfusion model establishment
The process of I/R injury in mice was similar to the process of inducing myocardial infarction (MI). 17 First, the mice (WT or tg-cast) were fixed on the mouse plate, and 2% isoflurane gas was applied through the mask to anesthetize the mice.Then made a 1 cm incision in the left 4th intercostal space. After blunt dissection of the pectoralis major and sternal external muscles, the heart was gently squeezed out. The left coronary artery (LCA) was ligated with 6-0 silk threads, and the heart was quickly pushed back into the chest. After 30 min's local ischemia duration, released the knot and achieved the reperfusion for 120 min(n=6/group). In sham operation groups, the chest was opened without LCA ligation (n=6/group).
Mitochondrial calcium uniporter inhibitor, Ru360, was dissolved in 0.9% saline solution and intraperitoneally administered (50nmol/ kg) half an hour before surgery (n = 6/group). Ru360 inhibits MCU specially without affecting actomyosin ATPase activity, sarcolemmal Na + /Ca 2+ exchange, sarcoplasmic reticulum Ca 2+ uptake or release, L-type Ca 2+ channel current.
| Infarct size estimation
After 30 minutes of ischemia and 120 minutes of reperfusion, LCA was re-tied and 1% Evans blue solution (Sigma-Aldrich) was injected into the right ventricle of the heart. The heart was quickly removed and frozen at −80°C, and was then cut into 2-mm-thick transverse slices. The slices were stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC) for 15 minutes. The myocardium was stained dark blue in the non-ischaemic area. The area at risk (RA) was dyed red, while the infarct area (INA) was white. The INA and RA were captured by Stereomicroscope (Leica) and measured by ImageJ 1.37 software and expressed as the percentage of INA/R.
| Morphological examination and apoptosis assays in risk area
Marginal area around I/R area was separated carefully from the heart.
The tissue was fixed in 4% paraformaldehyde, desiccated, embedded in paraffin and sliced for TUNEL assay and immunohistochemistry. 
| Cardiomyocyte culture and induction of H/R
Neonatal rat (1-3 days old, Department of Laboratory Animal Science, Fudan University) ventricular cardiomyocytes were isolated as previously described with a few modifications. 18 In brief, hearts of neonatal mice were isolated surgically, and the ventricles were enzymatically digested in 0.1% collagenase II for 10 minutes in an automatic heat regulator at 37°C. After centrifugation and resuspension, cells were preplaced for 2 hours in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (Gibco) to reduce fibroblasts, then plated in culture dishes and incubated at 37°C in a 5% CO 2 incubator.
To mimic the I/R injury, myocytes were treated with hypoxia/reoxygenation (H/R). Briefly, the isolated myocardial cells, adhered to the well with normal pulsation, were moved to a hypoxia incubator (1% O 2 , 94% N 2 and 5% CO 2 ) for 12 hours, followed by reoxygenation in normoxic conditions for 3 hours at 37°C.
Calpain inhibitor I, PD150606, was supplemented to culture media half an hour before H/R to inhibit calpain activity with concentration of 10 μmol/L.
| Cell viability and injury assay
Cell viability was measured by CCK8 assay, cardiomyocyte was incubated on a 96-pore plate and pretreated (2000 cells/pore), and 10 µL CCK8 solution (Beyotime, Shanghai, China, C0037) was added to each pore. After incubation in cell incubator for 1 hour, the cardiomyocyte was detected by enzyme-labelled instrument (Thermo, America) with a wavelength at 450 nm. The supernatant was collected after various treatments to measure the LDH levels using a commercial available kit (Beyotime Institute of Biotechnology, Shanghai, China; C0016) according to the manufacturer's instructions. After that, PVDF membranes were washed with TBST three times and incubated with the HRP-conjugated secondary antibody at room temperature for 1h. CoxIV (1:1000, 4850, CST) and GAPDH (1:10 000, 5174, CST) were used as internal control. An ECL-HRP chemiluminescence kit was used to visualize the bands that were quantified by Image Lab Software (Bio-Rad, USA). All samples were analysed in triplicate with a multilabel reader (excitation, 360 nm; emission, 460 nm, Thermo, America) and expressed as relative fluorescence units (RFU).
| Western blot analysis

| Calpain activity
A fluorometric calpain activity assay kit (ab65308, Abcam) was used to quantify calpain activity. In simple terms, the lysates of myocardial cells or heart tissue were centrifuged, and the supernatant was used to detect calpain activity using the fluorescent substrate N-succinyl-LLVY-AMC. All samples were analysed in triplicate with a multilabel reader (excitation, 360 nm; emission, 460 nm, Thermo, America) and expressed as relative fluorescent units (RFU).
| Confocal microscopy for the morphology of mitochondria
The cell culture medium was first removed, and MitoTracker Green (100 nmol/L, C1048, Beyotime) preheated to 37°C was added to wells. Cardiomyocytes with staining solution were incubated at 37°C for 30 minutes. After that, the staining solution replaced with fresh cell culture medium. These wells were observed under laser confocal microscopy Green (Leica Germany). The index of fragmentation is analysed by ImageJ. The mitochondrial length is measured by scale tools in Leica microscopy to present the level of mitochondrial fusion.
| Flow cytometric detection of apoptosis
The Annexin V-FITC Apoptosis Detection Kit microscopy (C1062, Beyotime Biotechnology) was applied under the manufacturer's instructions for apoptosis detection. In brief, primary cardiomyocytes were moulded, harvested after trypsinization treatments and washed twice with PBS; the cells were resuspended in 195 µL binding buffer, stained with Annexin V-FITC and then subsequently incubated with both 5 µL of Annexin V-FITC and 10 µL of the PI working substrate for 20 minutes at room temperature in the dark. Cellular fluorescence was measured by flow cytometry analysis (Becton-Dickinson, USA). In the early stages of apoptosis, cells were Annexin V-positive, while cells that were both PI-and Annexin V-positive were at the later stages, whereas cells that were only PI-positive were necrotic.
| Cytoplasm and mitochondrial protein preparation
Cardiomyocytes were digested with Trypsin-EDTA solution, centrifuged at room temperature (100-200 g) and washed with PBS.
Added mitochondria separation solution, the suspended cells were ground 20 times in the homogenizer and then centrifuged at 4°C (1000 g). The supernatant was carefully transferred to another EP tube and then centrifuged (10 000 g). Mitochondrial lysate (containing PMSF) was added into the precipitate (mitochondria) to obtain mitochondrial protein. The supernatant of the above steps continued to centrifuge (12 000 g), and cytoplasmic protein remained after abandoning the precipitate. The protein concentration was measured with the BCA protein assay kit. Unless otherwise specified, the above steps were experimented on ice.
| Intracellular ATP detection
The mitochondria lysate liquid replaced the culture medium. After centrifugation (4°C, 5 min, 12 000 g), the supernatant was carefully aspirated and placed on ice. Next, 100 µL ATP working liquid was in each test well and laid aside for 3-5 minutes at room temperature so that the background ATP was consumed. The sample above was added to the test wells in turn and rapidly mixed in a micropipette.
Multiscan spectrum measures the wells in relative light units (RLU)
by chemiluminescence (with a luminometer). Then, the ATP concentration was calculated according to the standard curve.
| Fluorescence quantitative detection of the calcium ion concentration in mitochondria
Cell mitochondria Ca 2+ concentration fluorescence quantitative detection reagent (GENMED SCIENTIFICS, GMS50097.1, USA), a type of mitochondrial calcium ion-specific fluorescent probe (Rhod-2), combined with calcium ions that can cause a remarkable increase in fluorescence intensity, was observed the relative change in the fluorescence peak under a fluorescence spectrophotometer instrument to determine the total calcium ion concentration in cellular mitochondria through classical technology and methods. A Mitochondrial Calcium Detection Kit was used for Ca 2+ detection under the manufacturer's instructions. Briefly, mitochondria were harvested from cardiomyocytes for subsequent use. A black 96-well cell culture plate was marked as bore cell samples, blank control (excluding mitochondria) and maximum contrast hole (excluding mitochondria). According to the instructions, reagents were added followed by incubation for 30 minutes at room temperature; then, incubation was performed for 30 minutes at 37°C under a fluorescence spectrophotometer instrument. All samples were analysed in triplicate with a multilabel reader (excitation, 550 nm; emission, 590 nm) and expressed in RFU. 
| RNA interference assays
| Statistical analysis
All statistical tests were analysed with GraphPad Prism 5, and the data were expressed as means ± SD. Statistical comparisons were conducted by Student's t test (for comparisons between two groups) or a one-way analysis of variance (ANOVA, for comparisons of three or more groups) followed by the Bonferroni post hoc test. P < .05 was considered statistically significant. 
| RE SULTS
| MCU was up-regulated under I/R injury, and MCU inhibition reduced infarction size and apoptosis in vivo
After I/R surgery, MCU protein expression in reperfusion area was upregulated in a time-dependent manner ( Figure 1A,B ). As MCU abundance was significantly increased after 3 hours of reperfusion and did not change afterword, we chose reperfusion for 3 hours in the subse- 
| MCU inhibition maintained mitochondrial morphology and homeostasis during I/R in vivo
Given the role of mitochondrial injury during I/R, we investigate the mitochondrial morphology by TEM. We found that the mitochondria were closely arranged with each other in a row, which was parallel to the sarcomere orientation in the sham group. In 
| MCU up-regulation played a role in H/Rinduced myocardial injury in vitro
To confirm the effect of MCU on I/R injury and to clarify the role of MCU, a cultured neonatal mouse cardiomyocytes model with H/R treatment was used to mimic myocardial injury. As expected, MCU expression increased during reoxygenation course and rose the most significantly after 12-h hypoxia and 3-h reoxygenation (Figure 2A,B) .
Thus, we performed 12h/3h in H/R treatment protocol and introduced Ru360 as MCU inhibitor or spermine as MCU activator, which has no effect on myocytes in normal state (Figure 2C 
| MCU activity modulated H/R-induced mitochondrial fission/fusion, mitophagy and ATP production in vitro
To confirm the effect of MCU on mitochondrial function after H/R stimulation, we compared the cellular ATP production between the groups.
The ATP production dropped markedly after H/R, while recovered with Ru360 treatment, and showed additional decrement with spermine treatment ( Figure 3A) . The key proteins of mitochondrial fission, fusion and mitophagy were examined by Western blot assay ( Figure 3B 
| MCU modulated calpains expression and activity under I/R stress in vivo and in vitro
To further explore the downstream of MCU modulation, we investigated the expression and activity of calpains, which is a type of calcium-depended protease after I/R injury in vivo and in vitro.
Based on histopathology and immunohistochemical stains, the expression of MCU, calpain-1 and calpain-2 was detected in slices of myocardial tissue of I/R area (Figure 4A Figure 4C-E) . In the molecular level, cellular free calcium concentration was varied in synchronicity with the expression of calpains ( Figure S1A ). Taken together, these evidence suggested MCU modulated calpains expression via cellular calcium homeostasis.
| Tg-CAST mice showed less myocardial injury, reduced mitochondrial fission and improved mitochondrial fusion an mitophagy during I/R by calpain inhibition
To further confirm the role of calpain activation in MCU-mediated I/R injury and mitochondrial disorder, Tg-CAST mice were used because calpastatin is a specific endogenous calpain-1/2 inhibitor without interfering other proteins. Firstly, the transgenic mice were genotyped to identify the correct littermates ( Figure   S1B ). Then, calpain protein expression and activity were examined. In normal state, the WT and Tg-CAST mice showed similar calpain protein expression. After I/R surgery, though the expression of calpain protein was elevated equally in both groups, calpain activity was significantly lower in Tg-CAST group than in WT ( Figure 5A-C) . Myocardial infarction size of Tg-CAST mice was reduced after I/R surgery compared to WT mice (Figure 5D,E) . Overly, these data implied calpain up-regulation and activation plays a role in I/R injury and MCU induced excessive mitochondrial fission and suppressed fusion/mitophagy.
| The protective effect of calpain inhibition on mitochondrial fission/fusion and mitophagy could be abolished by OPA1 knockout
To investigate the role of OPA1 in MCU-calpain-mediated I/R injury and mitochondrial disorder, we introduced PD150606 (10 μmol/L) as calpain inhibitor, and OPA1 siRNA to down-regulate OPA1 in primary cardiomyocytes before H/R was performed.
The efficiency of OPA1 siRNA was verified by Western blot, and the expression of OPA1 was significantly reduced after siRNA transfection ( Figure S1C ). Mitochondrial OPA1 expression was reduced during I/R and recovered when calpain or MCU was inhibited ( Figures 3B and 5F ). Mitochondrial proteins were examined in myocytes under H/R with PD150606 and OPA1 siRNA pretreatment ( Figure 6A 
| D ISCUSS I ON
In this study, we demonstrated one of the mechanisms of myocardial I/R injury. MCU is up-regulated during myocardial I/R, which increases the expression of cytoplasm and calpains and activates them. Activated calpains down-regulate OPA1-mediated mitochondrial fusion and mitophagy, promote mitochondrial fission, damage mitochondrial homeostasis and mitochondrial function, and promote apoptosis.
Several studies have shown that MCU is over-open during I/R
and participates in I/R injury through the mechanism of MCU-Ca 2+ overload-mPTP opening. 8, 19, 20 In the present study, mito- 9 Previous studies have shown that calpain activation can cause cardiac dysfunction and apoptosis through a variety of signalling pathways. 23 In mitochondria, activated calpain cleaves and modifies apoptosis-inducing factor in mitochondria to release it from mitochondria to cytoplasm and initiate apoptosis. 24 Recently, Ni R et al reported that calpain can degrade mitochondrial respiratory chain protein ATP synthase-a (ATP5A1), interfere with ATP synthesis and promote ROS production. 25 In this study, Tg-CAST model was established to observe the effect of calpain on mitochondrial dynamics. We found that calpain activation promotes mitochondrial fission, inhibits fusion and mitophagy and aggravates apoptosis. At present, the effect of calpain on mitochondrial fusion-related protein has been rarely reported. Calpain can inhibit the acetylation of MFN2 in liver I/R injury, which results in the interference of mitophagy and the damage of mitochondrial function. 26 In the model of neuroblastoma SH-SY5Y cells and cerebellar granule neurons, calpain activation down-regulates OPA1, inhibits mitochondrial fusion and increases mitochondrial fragmentation. 12, 16 We speculate that calpain affects mitochondrial fission/fusion and mitophagy by regulating OPA1, but it is not clear whether calpain has direct or indirect effects on OPA1.
In myocardial injury I/R, promoting mitochondrial fusion and autophagy can improve mitochondrial morphology, increase ATP production and reduce mitochondrial-derived apoptosis. 27 In the retinal ganglion cells model, OPA1 dominant not only mitochondrial fusion, but also mitophagy. 28 In recent years, increasing evidence has shown that OPA1 has protective effects in various cardiac diseases, especially in I/R. 29 Elevating the expression of OPA1 by drug preconditioning or overexpression of OPA1 in transgenic cells could improve the morphology and function of mitochondria and reduce myocardial injury. 30, 31 However, conditioned OPA1 knock-down aggravates mitochondrial dysfunction and cell damage. 32 This study found that OPA1 is downstream of MCU/calpain. Up-regulation of MCU/calpain inhibits OPA1 during I/R, inhibits mitochondrial fusion and autophagy, promotes mitochondrial fragmentation and initiates apoptotic process.
In conclusion, we established I/R models in vivo and in vitro and demonstrated that MCU is up-regulated during I/R and activates calpain by mitochondrial calcium overload. And then, calpain inhibits OPA1; thus, mitochondrial fusion and mitophagy are inhibited to promote mitochondrial fission, leading to mitochondrial morphological and functional damage, and activation of intrinsic apoptosis pathway.
This study suggests that MCU-calpain-OPA1 signalling pathway is, at least, one of the mechanisms of myocardial I/R injury ( Figure S1D ).
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